Reham Ebaid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reham Ebaid has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abd El-Fatah Abomohra
Aquatic Ecophysiology and Phycology, Institute of Plant Science and Microbiology, University of Hamburg, 22609 Hamburg, Germany
2 shared publications - Hamed Eladel
Benha University
2 shared publications - Mostafa Mohammed El-Sheekh
Botany and Microbiology Department, Faculty of Science, Tanta University, Tanta 31527, Egypt
2 shared publications Hao Shang
School of Energy and Power Engineering, Jiangsu University, 212013 Jiangsu, China
1 shared publicationQian Wang
School of Energy and Power Engineering, Jiangsu University, 212013 Jiangsu, China
1 shared publication- Shuang Wang
School of Energy and Power Engineering, Jiangsu University, Zhenjiang 212013, China
1 shared publication
Latest Publications
- 1 September 2019
- Published by Elsevier in Bioresource Technology
- Vol. 288, 121514
Night illumination using monochromatic light-emitting diodes for enhanced microalgal growth and biodiesel production
- 1 September 2019
- Published by Elsevier in Bioresource Technology
- Vol. 288, 121514
Night illumination using monochromatic light-emitting diodes for enhanced microalgal growth and biodiesel production
- Open Access
- 30 March 2019
- Published by Editorial CSIC in Grasas y Aceites
- Vol. 70 (1) , e292
Pharmaceutical applications and consequent environmental impacts of Spirulina (Arthrospira): An overview
Recently, microalgae cultivation for different applications, including the production of nutritional and pharmaceutical active compounds has received increasing attention. Among the different genera, Spirulina (Arthrospira sp.) is one of the most promising blue-green microalgae (Cyanophyta) because it is rich in antioxidants, essential amino acids (EAAs), minerals, proteins, polyunsaturated fatty acids and vitamins. It has a high protein content (60-70% of the dry weight), which is a complete protein, i.e. containing all EAAs. Therefore, Spirulina is currently a commercial product with high nutritional value and also a significant source of complementary and alternative medicine. The objective of the present work was to review the pharmaceutical and therapeutic applications of Spirulina, especially its antioxidant, anti-inflammatory, anti-cancer, anti-microbial, anti-diabetic, anti-obesity and anti-toxicity properties. The results were obtained from experiments in the literature performed in vitro and in vivo using experimental animals. The main reported active ingredients in Spirulina include phycocyanin, tocopherol, β-carotene, caffeic acids and chlorogenic acid, which showed individual or synergetic effects. In addition, the present review discusses the future perspectives of genetically modified Spirulina as a source for industrial products while producing valuable biomass photoautotrophically. Furthermore, the consequent environmental impacts of large-scale cultivation of Spirulina are discussed.
- 30 March 2019
- Published by Editorial CSIC in Grasas y Aceites
- Vol. 70 (1) , e292
Open AccessPharmaceutical applications and consequent environmental impacts of Spirulina (Arthrospira): An overview
Recently, microalgae cultivation for different applications, including the production of nutritional and pharmaceutical active compounds has received increasing attention. Among the different genera, Spirulina (Arthrospira sp.) is one of the most promising blue-green microalgae (Cyanophyta) because it is rich in antioxidants, essential amino acids (EAAs), minerals, proteins, polyunsaturated fatty acids and vitamins. It has a high protein content (60-70% of the dry weight), which is a complete protein, i.e. containing all EAAs. Therefore, Spirulina is currently a commercial product with high nutritional value and also a significant source of complementary and alternative medicine. The objective of the present work was to review the pharmaceutical and therapeutic applications of Spirulina, especially its antioxidant, anti-inflammatory, anti-cancer, anti-microbial, anti-diabetic, anti-obesity and anti-toxicity properties. The results were obtained from experiments in the literature performed in vitro and in vivo using experimental animals. The main reported active ingredients in Spirulina include phycocyanin, tocopherol, β-carotene, caffeic acids and chlorogenic acid, which showed individual or synergetic effects. In addition, the present review discusses the future perspectives of genetically modified Spirulina as a source for industrial products while producing valuable biomass photoautotrophically. Furthermore, the consequent environmental impacts of large-scale cultivation of Spirulina are discussed.